• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎盘3β-羟基-δ5-类固醇脱氢酶的调控:一种内源性抑制剂和一种内源性激活剂的部分特性

Control of placental 3 beta-hydroxy-delta 5-steroid dehydrogenase: partial characterization of an endogenous inhibitor and an endogenous activator.

作者信息

Wiener M

出版信息

Mech Ageing Dev. 1978 Jun;7(6):433-44.

PMID:672264
Abstract

Two substances which affect the activity and kinetic characteristics of 3 beta-hydroxy-delta 5-steroid dehydrogenase (delta 5-3 beta-HSD) have been recovered from homogenates of term human placenta by extraction with organic solvents after ethanol precipitation of protein. One of these substances, an inhibitor of the enzyme, is a non-polar unstable substance, which dialyzes through a cellulose nitrate membrane and which appears to be present in the tissue both in the free state and bound to either the enzyme or the microsomal membrane. It was not possible to produce a delta 5-3 beta-HSD preparation free of the inhibitor. The other substance is an activator, polar and stable with a molecular weight of less then 500, which increases both the apparent Km and the apparent V max of delta 5-3 beta-HSD. It is postulated that both substances play a part in control of placental progesterone synthesis.

摘要

通过对人足月胎盘匀浆进行乙醇沉淀蛋白质后用有机溶剂萃取,已从其中分离出两种影响3β-羟基-δ5-甾体脱氢酶(δ5-3β-HSD)活性及动力学特性的物质。其中一种物质是该酶的抑制剂,为非极性不稳定物质,可透过硝酸纤维素膜进行透析,且似乎在组织中以游离状态存在,同时也与酶或微粒体膜结合。无法制备出不含该抑制剂的δ5-3β-HSD制剂。另一种物质是激活剂,具有极性且稳定,分子量小于500,它可同时增加δ5-3β-HSD的表观Km值和表观Vmax值。据推测,这两种物质在胎盘孕酮合成的调控中均发挥作用。

相似文献

1
Control of placental 3 beta-hydroxy-delta 5-steroid dehydrogenase: partial characterization of an endogenous inhibitor and an endogenous activator.胎盘3β-羟基-δ5-类固醇脱氢酶的调控:一种内源性抑制剂和一种内源性激活剂的部分特性
Mech Ageing Dev. 1978 Jun;7(6):433-44.
2
Control of placental 3 beta-hydroxy-delta 5-steroid dehydrogenase: an apparent endogenous regulator of porgesterone synthesis.胎盘3β-羟基-δ5-类固醇脱氢酶的调控:孕酮合成的一种明显内源性调节因子。
Mech Ageing Dev. 1978 Jun;7(6):445-53. doi: 10.1016/0047-6374(78)90085-4.
3
Follicle regulatory protein noncompetitively inhibits microsomal 3 beta-hydroxysteroid dehydrogenase activity.卵泡调节蛋白非竞争性抑制微粒体3β-羟类固醇脱氢酶活性。
J Steroid Biochem. 1985 Nov;23(5A):663-8. doi: 10.1016/0022-4731(85)90019-6.
4
Kinetic analysis of human placental, ovarian, and adrenal 3 beta-hydroxysteroid dehydrogenase inhibition by epostane in vitro.
J Steroid Biochem. 1989 Sep;33(3):483-5. doi: 10.1016/0022-4731(89)90340-3.
5
Microsomal 20 alpha-hydroxysteroid dehydrogenase activity for progesterone in human placenta.人胎盘中孕酮的微粒体20α-羟基类固醇脱氢酶活性
Endocrinol Jpn. 1986 Jun;33(3):361-8. doi: 10.1507/endocrj1954.33.361.
6
Active site-directed irreversible inhibition of 3 beta-hydroxysteroid dehydrogenase from human placenta.
J Steroid Biochem. 1983 Aug;19(2):1213-7. doi: 10.1016/0022-4731(83)90419-3.
7
Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis.2型11β-羟类固醇脱氢酶信使核糖核酸及其在人胎盘和胎膜中的活性:其与出生体重的关系以及在胎儿肾上腺类固醇生成中的假定作用。
J Clin Endocrinol Metab. 1995 Mar;80(3):885-90. doi: 10.1210/jcem.80.3.7883847.
8
Kinetic analysis of the placental microsomal 3 beta-hydroxysteroid dehydrogenase activity.
Steroids. 1979 Apr;33(4):459-66. doi: 10.1016/0039-128x(79)90018-7.
9
Topology of 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase in adrenal cortex mitochondria and microsomes.肾上腺皮质线粒体和微粒体中3β-羟基-5-烯-类固醇脱氢酶/δ5-δ4-异构酶的拓扑结构
Endocrinology. 1994 Feb;134(2):751-9. doi: 10.1210/endo.134.2.8299570.
10
Steroid inhibitory effects upon human adrenal 3 beta-hydroxysteroid dehydrogenase activity.类固醇对人肾上腺3β-羟基类固醇脱氢酶活性的抑制作用。
J Clin Endocrinol Metab. 1986 Feb;62(2):413-8. doi: 10.1210/jcem-62-2-413.